Body mass index and lung function decline in persistent asthma - 01/09/25
Doi : 10.1016/j.rmed.2025.108304
Rory Chan, PhD, FRCPE a, ⁎ 
, Marcello Cottini, MD b, Francesco Menzella, MD, PhD c, Remo Poto, MD, PhD d, e, f, Zuzana Diamant, MD, PhD, FERS g, h, i, Sven F. Seys, MD, PhD j
, Marcello Cottini, MD b, Francesco Menzella, MD, PhD c, Remo Poto, MD, PhD d, e, f, Zuzana Diamant, MD, PhD, FERS g, h, i, Sven F. Seys, MD, PhD j a University of Dundee, School of Medicine, Dundee, UK
b Allergy and Pneumology Outpatient Clinic, Bergamo, Italy
c Pulmonology Unit, S. Valentino Hospital, Montebelluna, TV, AULSS2 Marca, Trevigiana, Italy
d Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy
e Center for Basic and Clinical Immunology Research (CISI) - University of Naples Federico II, Naples, Italy
f Istituti Clinici Scientifici Maugeri-IRCCS Scientific Institute of Telese Terme, Benevento, Italy
g Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands
h Dept Microbiology Immunology & Transplantation Ku Leuven, Leuven, Belgium
i Department of Respiratory Medicine, First Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czech Republic
j Galenus Health, Hasselt, Belgium
⁎ Corresponding author.
Le texte complet de cet article est disponible en PDF.
Plan
© 2025
Elsevier Ltd. Tous droits réservés.
Vol 247
Article 108304- octobre 2025 Retour au numéro
Article précédent
- Editorial Board
- Prognostic performance of the 3- and 4-strata ESC/ERS risk stratification models in Pulmonary Arterial Hypertension: A validation study in a Saudi Arabian cohort
- Abdullah AlHarbi, Abdalaziz Biyari, Abdulrahman Basuwdan, Osama Alrodiman, Abdullah Basuliman, Bader Alyousef
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?